Benitec Biopharma Inc. SEC filings BNTC
Benitec Biopharma Inc. has 334 filings in SEC EDGAR's recent list, going back to Apr 15, 2020. Its latest annual report, Form 10-K, was filed on Sep 14, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (regulation fd disclosure). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Sep 14, 2026 | — |
| 424B3 | Prospectus | Feb 11, 2026 | — |
| S-3 | Shelf registration | Jan 30, 2026 | — |
| 424B5 | Prospectus supplement | Nov 7, 2025 | — |
| 424B5 | Prospectus supplement | Nov 5, 2025 | — |
| S-3 | Shelf registration | Sep 22, 2025 | — |
| 424B3 | Prospectus | Jun 2, 2025 | — |
| S-3 | Shelf registration | May 23, 2025 | — |
| 424B5 | Prospectus supplement | Mar 26, 2025 | — |
| S-3 | Shelf registration | Nov 1, 2024 | — |
| 424B5 | Prospectus supplement | Oct 15, 2024 | — |
| 424B5 | Prospectus supplement | Oct 11, 2024 | — |
| S-8 | Employee stock plan registration | Oct 1, 2024 | — |
| 424B3 | Prospectus | May 29, 2024 | — |
| S-1 | Registration statement | May 16, 2024 | — |
| S-3 | Shelf registration | Feb 23, 2024 | — |
| S-8 | Employee stock plan registration | Dec 26, 2023 | — |
| 424B4 | Prospectus | Aug 10, 2023 | — |
| S-1/A | Amended registration statement | Aug 7, 2023 | — |
| S-1/A | Amended registration statement | Aug 3, 2023 | — |
| S-1/A | Amended registration statement | Jul 31, 2023 | — |
| S-1 | Registration statement | Jul 7, 2023 | — |
| S-1 | Registration statement | Dec 13, 2022 | — |
| 424B4 | Prospectus | Sep 14, 2022 | — |
| S-1/A | Amended registration statement | Sep 12, 2022 | — |
| S-1/A | Amended registration statement | Sep 9, 2022 | — |
| S-1/A | Amended registration statement | Aug 10, 2022 | — |
| S-1/A | Amended registration statement | Aug 8, 2022 | — |
| S-1 | Registration statement | Jul 29, 2022 | — |
| S-8 | Employee stock plan registration | Dec 23, 2021 | — |
| 424B5 | Prospectus supplement | Apr 29, 2021 | — |
| FWP | Free writing prospectus | Apr 28, 2021 | — |
| FWP | Free writing prospectus | Apr 27, 2021 | — |
| 424B5 | Prospectus supplement | Apr 27, 2021 | — |
| S-3 | Shelf registration | Feb 18, 2021 | — |
| S-8 | Employee stock plan registration | Feb 18, 2021 | — |
| 424B4 | Prospectus | Oct 6, 2020 | — |
| S-1/A | Amended registration statement | Oct 1, 2020 | — |
| S-1 | Registration statement | Aug 14, 2020 | — |
Showing 39 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BNTC (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Hayward, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1808898
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.